SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Marksans Pharma - Quaterly Results

09 Nov 2023 Evaluate
The company witnessed a 20.21% growth in the revenue at Rs. 2046.73 millions for the quarter ended September 2023 as compared to Rs. 1702.59 millions during the year-ago period.Net profit declined -22.22% to Rs. 312.89 millions from Rs. 402.29 millions.Operating Profit reported a sharp decline to 532.30 millions from 548.05 millions in the corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202309 202209 % Var 202309 202209 % Var 202303 202203 % Var
Sales 2046.73 1702.59 20.21 3867.14 3294.11 17.40 6552.04 6582.89 -0.47
Other Income 159.31 210.34 -24.26 485.54 404.66 19.99 604.82 422.51 43.15
PBIDT 532.30 548.05 -2.87 1126.11 858.44 31.18 1523.85 1559.66 -2.30
Interest 2.31 12.91 -82.11 4.93 21.08 -76.61 36.13 37.95 -4.80
PBDT 529.99 535.14 -0.96 1121.18 837.36 33.89 1487.72 1521.71 -2.23
Depreciation 84.98 45.30 87.59 132.22 90.48 46.13 167.37 176.63 -5.24
PBT 445.01 489.84 -9.15 988.96 746.88 32.41 1320.35 1345.08 -1.84
TAX 132.12 87.55 50.91 234.16 152.53 53.52 291.69 305.20 -4.43
Deferred Tax 15.36 1.88 717.02 42.30 0.94 4400.00 -1.71 5.04 -133.93
PAT 312.89 402.29 -22.22 754.80 594.35 27.00 1028.66 1039.88 -1.08
Equity 453.16 404.23 12.10 453.16 409.31 10.71 453.16 409.31 10.71
PBIDTM(%) 26.01 32.19 -19.20 29.12 26.06 11.74 23.26 23.69 -1.84

Marksans Pharma Share Price

179.55 -0.95 (-0.53%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×